alanine has been researched along with bendamustine hydrochloride in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrientos, JC | 1 |
| Asai, A; Inoue, Y; Iwamoto, K; Matsuno, K; Muraoka, D; Ogo, N; Taguchi, K; Uehara, Y | 1 |
1 review(s) available for alanine and bendamustine hydrochloride
| Article | Year |
|---|---|
Sequencing of chronic lymphocytic leukemia therapies.
Topics: Alanine; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cell Proliferation; Chlorambucil; Chromosome Deletion; Chromosomes, Human, Pair 17; Cyclophosphamide; Disease-Free Survival; DNA Mutational Analysis; High-Throughput Nucleotide Sequencing; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Rituximab; Smith-Magenis Syndrome; Tumor Suppressor Protein p53 | 2016 |
1 other study(ies) available for alanine and bendamustine hydrochloride
| Article | Year |
|---|---|
Inhibition of STAT3 by Anticancer Drug Bendamustine.
Topics: Alanine; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Binding Sites; Cell Line, Tumor; Cysteine; Drug Screening Assays, Antitumor; Gene Expression; Humans; Peptides; Phosphotyrosine; Point Mutation; Protein Binding; src Homology Domains; STAT3 Transcription Factor; Structure-Activity Relationship | 2017 |